Epidermal growth factor receptor (EGFR), placental alkaline phosphatase (PLAP), and leucine-rich alpha-2 glycoproteins (LRG1) are potential biomarkers for non-small cell lung cancer, as they are all overexpressed in patients. This evidence concerns the gene EGFR and non-small cell lung carcinoma.